WW WW International Inc.

WeightWatchers Appoints New Executive Leaders

WeightWatchers Appoints New Executive Leaders

The Company bolsters leadership team with seasoned hires from Teladoc Health and 23andMe

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the appointment of new executives to the Company’s leadership team as it builds for the future, supporting its purpose to help people live healthier, longer​: Donna Boyer, as Chief Product Officer, Jacquie Cooke, as General Counsel and Secretary, and Debra Benovitz who has been elevated to Chief Insights Officer.

Donna Boyer will join the Company as Chief Product Officer, effective May 1, to drive the WeightWatchers product mission and strategy across the member experience, and champion cohesion across the end-to-end consumer journey. Most recently, Donna was the Chief Product Officer at Teladoc Health, where she led the strategic shift from a single product to a multi-product portfolio organization. Donna joined Teladoc Health as the SVP of Product and Design in 2020 and was promoted to Chief Product Officer within six months. She was instrumental in the integration and expansion of multiple organic and acquired product lines as well as launching new product offerings. Prior to Teladoc Health, Donna served as VP of Product and Design at Stitch Fix shortly after the company’s IPO to build and operationalize its product functions while diversifying its product offerings. Prior to Stitch Fix, Donna was Head of Product for Airbnb’s Hosts & Homes and later led the development of Airbnb Plus. Donna spent her early career in product management at Hyperion, which was later acquired by Oracle, as well as Digital Think and Yahoo!.

Jacquie Cooke has joined the Company as General Counsel and Secretary to bring forward her extensive legal background in biotechnology and significant experience in regulatory and compliance matters as it pertains to healthcare. Prior to joining WeightWatchers, Jacquie served as General Counsel and Privacy Officer at 23andMe where she helped scale the business, owning the legal, data protection and compliance functions. She helped to lead the company through its go-public transaction as well as its acquisition and integration of Lemonaid Health, a telehealth platform and digital pharmacy. She joined 23andMe as Associate General Counsel in 2015. Prior to 23andMe, Jacquie was Senior Commercial Counsel for Genomic Health, a provider of genomic-based diagnostic tests that help optimize cancer care. At Genomic Health, she served as advisor to commercial teams and led health care compliance globally. Jacquie spent her early career as an associate at Latham & Watkins.

Debra Benovitz joined WeightWatchers in 2014 as SVP of Global Consumer Insights to guide the WeightWatchers user experience across product and marketing with data-backed insights. She joined the Company’s leadership in 2015, and her role has become even more essential to guarantee all cross-functional touchpoints resonate with WeightWatchers members. Her recent promotion to Chief Insights Officer expands her role to oversee all science and clinical research, including WeightWatchers #1 doctor recommended Points Program. Debra’s cross-functional oversight ensures consumer needs are met with what WeightWatchers science and medical teams can responsibly deliver with sustainability and efficacy across behavioral and clinical interventions to help people with better health outcomes. With more than 30 years of consumer insights experience, Debra has made significant contributions to WeightWatchers, delivering strategic consumer insights that drive business growth. Prior to WeightWatchers, Debra served as Vice President, Global Consumer Insights at PepsiCo. She also served key leadership roles at LEGO and Dove.

“As we focus our efforts on expanding care and expanding access to provide a full spectrum of comprehensive weight health offerings, Donna, Jacquie and Deb will play an essential role in shaping the future direction of the organization with their unique expertise and insights,” said Sima Sistani, CEO, WeightWatchers. “I welcome Donna and Jacquie and believe that with the two of them alongside Deb and the rest of the leadership team, we are positioned strongly for the future.”

About WW International, Inc.

WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management programs. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our programs. To learn more about the WeightWatchers approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com.

For more information, contact:

Investors:

Corey Kinger

Media:

Kelsey Merkel



EN
11/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WW International Inc.

 PRESS RELEASE

WeightWatchers Completes Financial Reorganization, Strengthens Leaders...

WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief Medical Officer The Company is advancing its first integrated women’s health initiative focused on perimenopause and menopause, combining medical, nutritional, lifestyle, and community-based support WeightWatchers successfully relists as a public company on Nasdaq under ticker WW NEW YORK, July 08, 20...

 PRESS RELEASE

WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medica...

WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industry Collaboration Builds a Seamless NovoCare® Pharmacy Integration, Shared Vision to Enhance Outcomes Through WW’s GLP-1 Companion Support, and a Commitment to Publishing Real-World Evidence WeightWatchers Sets the Standard in Evidence-Based Weight Health, Prescribing Only ...

 PRESS RELEASE

WeightWatchers’ Reorganization Plan Confirmed, Clears Path for Elimina...

WeightWatchers’ Reorganization Plan Confirmed, Clears Path for Elimination of Majority of Legacy Debt Burden and Execution of Transformation Plan On Track to Exit Financial Reorganization Process Next Week, Company to Focus on Scaled Delivery of Its Comprehensive, Best-in-Class Weight Management Platform, Integrating Community, Behavioral, and Medical Solutions NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- WW International, Inc., the global leader in science-backed weight management (“WeightWatchers” or the “Company”), today announced that, following approval of its Plan of Reorganization...

 PRESS RELEASE

CheqUp and WeightWatchers Announce Strategic Partnership to Support Gr...

CheqUp and WeightWatchers Announce Strategic Partnership to Support Growing Use of GLP-1 Medications in the UK Partnership Provides CheqUp Members Access to WeightWatchers’ Proven GLP-1 Companion Programme to Aid in Achieving Superior and Sustainable Results CHIPPENHAM, England, May 22, 2025 (GLOBE NEWSWIRE) -- , one of the UK’s leading providers of GLP-1 based weight loss services, and , the global leader in science-backed weight management, have announced a partnership that will combine the offerings of both organizations to benefit patients seeking sustainable weight loss through GLP...

 PRESS RELEASE

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of De...

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved 57% year-over-year revenue growth in Q1 2025 Enters comprehensive agreement with lenders and noteholders to significantly reduce its debt obligations and bolster financial flexibility ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch